Civic Intelligence

Immunotherapy Foundation

EIN 47-3847309 • 501(c)3 • San Diego, CA

Profile

Immunotherapy Foundations (IF) initial mission is to find an effective treatment, and ultimately a cure for HPV-related cancers through the partnering and funding of research, studies and revolutionary treatments broadly known as immunotherapy. This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs.All projects will be designed to bring promising human therapies to the clinic. The projects will address the biology of HPV-related cancers, particularly those of the head and neck. The current research shows promise to extend to other malignancies. The projects are tightly interconnected to leverage information, allowing efficient movement into the clinic.

9191 Towne Centre Drive 310San Diego, CA 92122

www.theimmunotherapyfoundation.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

69th percentile

0.02x

Higher debt load relative to assets than 69% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2021

Liabilities / Revenue

79th percentile

0.06x

Higher debt load relative to revenue than 79% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2021

Net Margin

5th percentile

-267%

Higher net margin than 5% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2021

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

13th percentile

-71%

Faster asset growth than 13% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2020 to 2021

Revenue Growth

5th percentile

-94%

Faster revenue growth than 5% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2020 to 2021

Assets

Down

$309,684

Down $774,956 (-71%) from 2020

Liabilities

Down

$5,131

Down $527,029 (-99%) from 2020

Net Assets

Down

$304,553

Down $247,927 (-45%) from 2020

Revenue

Down

$92,766

Down $1,557,901 (-94%) from 2020

Expenses

Down

$340,693

Down $1,192,858 (-78%) from 2020

Net Income

Down

-$247,927

Down $365,043 (-312%) from 2020

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$2.0M$1.5M$1.0M$500K$0Assets 2015: $1,829,474Liabilities 2015: $0Net Assets 2015: $1,829,4742015Assets 2016: $1,367,985Liabilities 2016: $0Net Assets 2016: $1,367,9852016Assets 2017: $1,195,424Liabilities 2017: $9,656Net Assets 2017: $1,185,7682017Assets 2018: $877,650Liabilities 2018: $9,883Net Assets 2018: $867,7672018Assets 2019: $446,267Liabilities 2019: $10,903Net Assets 2019: $435,3642019Assets 2020: $1,084,640Liabilities 2020: $532,160Net Assets 2020: $552,4802020Assets 2021: $309,684Liabilities 2021: $5,131Net Assets 2021: $304,5532021

Highlighted filing

2021

Assets$309,684
Liabilities$5,131
Net Assets$304,553

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2015: $4,604,110Expenses 2015: $2,774,636Net Income 2015: $1,829,4742015Revenue 2016: $835,439Expenses 2016: $1,296,928Net Income 2016: -$461,4892016Revenue 2017: $267,707Expenses 2017: $449,924Net Income 2017: -$182,2172017Revenue 2018: $483,908Expenses 2018: $817,470Net Income 2018: -$333,5622018Revenue 2019: $832,651Expenses 2019: $1,265,054Net Income 2019: -$432,4032019Revenue 2020: $1,650,667Expenses 2020: $1,533,551Net Income 2020: $117,1162020Revenue 2021: $92,766Expenses 2021: $340,693Net Income 2021: -$247,9272021

Highlighted filing

2021

Revenue$92,766
Expenses$340,693
Net Income-$247,927

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Nov 15, 2022
Return Version
2021v4.1
Gross Receipts
$92,766
Mission and Program Overview

Mission

Immunotherapy Foundations (IF) initial mission is to find an effective treatment, and ultimately a cure for HPV-related cancers through the partnering and funding of research, studies and revolutionary treatments broadly known as immunotherapy. This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs.All projects will be designed to bring promising human therapies to the clinic. The projects will address the biology of HPV-related cancers, particularly those of the head and neck. The current research shows promise to extend to other malignancies. The projects are tightly interconnected to leverage information, allowing efficient movement into the clinic.

Program Services

DescriptionGrantsExpenses
Our cause is to fund the following programs and studies:A cutting-edge cancer mutanome focused personalized immunotherapy program.A novel immune therapy for head and neck squamous cell carcinoma (HNSCC) that lays the framework for developing drugs, antibodies, and vaccines against cancers.Identification of a novel immune biomarker in the RNA sequence that allows us to predict and assess a patients response to immunotherapy.A robust clinical trial portfolio of immunotherapies for patients with HPV-related cancers, stressing studies with novel therapies, translational research, and biomarker discovery.-$165,784
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Christina B JordanExecutive DirectorFT$160,000-$160,000
FERNANDA L WHITWORTHPresidentPT$0--
MARK MINASIANTreasurer-$0--
RANDY WOODSSecretary-$0--
Filing and Contact Details

Filer

Filer Name
Immunotherapy Foundation
EIN
47-3847309
Phone
8583810823
Address
9191 TOWNE CENTRE DRIVE 310, SAN DIEGO, CA 92122

Signing Officer

Name
Fernanda L Whitworth
Title
President
Signed
2022-11-15
Discuss with paid preparer
Yes

Preparer

Firm
Meletis and Munsch LLP
Address
12636 High Bluff Dr Ste 350, San Diego, CA 92130
Preparer
Karyn L Meletis Partner
Phone
8582995900
Supplemental Narrative

Additional Explanations

Other Revenue.1

OTHER INCOME $48551

Other Revenue.2

CREDIT CARD REBATES $20

Other Expenses.1001

Advertising and Promotion $5860

Other Expenses.1002

Office Expenses $12204

Other Expenses.1005

Travel $2840

Other Expenses.1012

Insurance $19237

Other Expenses.1

Events & fundraising $42871

Other Expenses.2

Dues & subscriptions $7568

Other Expenses.3

Bank service charges $934

Other Expenses.5

UTILITIES $528

Other Expenses.6

LICENCE AND PERMIT $204

Other Assets.1

- Beginning $8672 - Ending $0

Total Liabilities.1002

Grants Payable - Beginning $525000 Grants Payable - Ending $0

Total Liabilities.1

ACCRUED PAYROLL - Beginning $7160 ACCRUED PAYROLL - Ending $5131

Raw XML Appendix186 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0IMMUNOTHERAPY FOUNDATION
IRS990EZ/BooksInCareOfDetail/PhoneNum08582995900
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt012636 High Bluff Dr Ste 350
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0San Diego
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092130
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt01075968
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0309684
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt041178
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-247927
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt011467
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt01084640
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0309684
IRS990EZ/FundraisingGrossIncomeAmt02925
IRS990EZ/GrossReceiptsAmt092766
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt092
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0552480
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0304553
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0552480
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0304553
IRS990EZ/OccupancyRentUtltsAndMaintAmt065299
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt020.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt140.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt1160000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0FERNANDA L WHITWORTH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Christina B Jordan
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2MARK MINASIAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3RANDY WOODS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Executive Dir.
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Secretary
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt08672
IRS990EZ/OtherExpensesTotalAmt092246
IRS990EZ/OtherRevenueTotalAmt048571
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Immunotherapy Foundations (IF) initial mission is to find an effective treatment, and ultimately a cure for HPV-related cancers through the partnering and funding of research, studies and revolutionary treatments broadly known as immunotherapy. This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs.All projects will be designed to bring promising human therapies to the clinic. The projects will address the biology of HPV-related cancers, particularly those of the head and neck. The current research shows promise to extend to other malignancies. The projects are tightly interconnected to leverage information, allowing efficient movement into the clinic.
IRS990EZ/PrintingPublicationsPostageAmt0768
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Our cause is to fund the following programs and studies:A cutting-edge cancer mutanome focused personalized immunotherapy program.A novel immune therapy for head and neck squamous cell carcinoma (HNSCC) that lays the framework for developing drugs, antibodies, and vaccines against cancers.Identification of a novel immune biomarker in the RNA sequence that allows us to predict and assess a patients response to immunotherapy.A robust clinical trial portfolio of immunotherapies for patients with HPV-related cancers, stressing studies with novel therapies, translational research, and biomarker discovery.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0165784
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt0170913
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SpecialEventsNetIncomeLossAmt02925
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt0532160
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt05131
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt0340693
IRS990EZ/TotalProgramServiceExpensesAmt0165784
IRS990EZ/TotalRevenueAmt092766
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0www.theimmunotherapyfoundation.org
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt048551
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01650603
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0832436
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0483425
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0267052
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt03282067
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt092
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt064
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0215
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0483
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0655
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt01509
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.66000
IRS990ScheduleA/PublicSupportPY170Pct00.56780
IRS990ScheduleA/PublicSupportTotal170Amt02167139
IRS990ScheduleA/SubstantialContributorsTotAmt01114928
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt048551
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01650603
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0832436
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0483425
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0267052
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt03282067
IRS990ScheduleA/TotalSupportAmt03283576
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0OTHER INCOME $48551
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1CREDIT CARD REBATES $20
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Advertising and Promotion $5860
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3Office Expenses $12204
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4Travel $2840
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5Insurance $19237
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6EVENTS & FUNDRAISING $42871
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7DUES & SUBSCRIPTIONS $7568
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt8BANK SERVICE CHARGES $934
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt9UTILITIES $528
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt10LICENCE AND PERMIT $204
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt11- Beginning $8672 - Ending $0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt12Grants Payable - Beginning $525000 Grants Payable - Ending $0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt13ACCRUED PAYROLL - Beginning $7160 ACCRUED PAYROLL - Ending $5131
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Revenue.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Revenue.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1001
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Other Expenses.1005
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Other Expenses.1012
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc8Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc9Other Expenses.5
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc10Other Expenses.6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc11Other Assets.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc12Total Liabilities.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc13Total Liabilities.1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/FederatedAssuranceLevelCd0FAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd02
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0Fernanda L Whitworth
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/SignatureDt02022-11-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0IMMUNOTHERAPY FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0IMMU
ReturnHeader/Filer/EIN0473847309
ReturnHeader/Filer/PhoneNum08583810823
ReturnHeader/Filer/USAddress/AddressLine1Txt09191 TOWNE CENTRE DRIVE 310
ReturnHeader/Filer/USAddress/CityNm0SAN DIEGO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092122
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0823382227
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Meletis and Munsch LLP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt012636 High Bluff Dr Ste 350
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0San Diego
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd092130
ReturnHeader/PreparerPersonGrp/PhoneNum08582995900
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0Karyn L Meletis Partner
ReturnHeader/ReturnTs02022-11-15T13:01:24-08:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0Fernanda L
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0Whitworth
ReturnHeader/TaxPeriodBeginDt02021-01-01
ReturnHeader/TaxPeriodEndDt02021-12-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.